QIAGEN has filed a solicitation/recommendation statement on Schedule 14D-9 with the SEC with respect to the tender offer on May 18, 2020, as amended from time to time; in addition, QIAGEN has published a document combining the recommendation statement pursuant to Sec. The amended business combination agreement has been terminated due to the acceptance threshold not having been met. QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. A subset of the HGMD gross deletions has now been mapped to both builds of the reference genome (NCBI38/hg38 and legacy NCBI37/hg19). The issuer is solely responsible for the content of this … - Offer price increased from €39.00 to €43.00 per QIAGEN share in cash - Minimum acceptance threshold lowered from 75% to 66.67% of outstanding QIAGEN shares - QIAGEN Supervisory and Managing Boards reaffirm unanimous recommendation that QIAGEN shareholders tender all of their QIAGEN shares Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and QIAGEN … DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution With disclosure dated November 11, 2020, QIAGEN N.V. announced pursuant to Article 5 Section (1) and (6) of the EU Regulation no 596/2014 and Article 2 Section (1) of the Delegated EU Regulation no … READ MORE. The announcement of the 15-year partnership of next generation sequencing (NGS) market leader Illumina and QIAGEN came after Illumina cut its 2019 guidance from 13-14% prior guidance and 13% consensus to 6% FY revenue growth after reporting a second-quarter revenue loss of approximately US$52m (US$835 million, lower … VENLO, The Netherlands--(BUSINESS WIRE)-- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that Dr. Toralf Haag has been appointed a member of the Supervisory Board with immediate effect.He will also become a member of the Audit Committee. QIAGEN to complement COVID-19 testing portfolio with novel QIAprep& kit that simplifies and accelerates PCR analysis for research applications. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. INVESTORS AND SHAREHOLDERS OF QIAGEN ARE URGED TO READ THESE DOCUMENTS CAREFULLY BECAUSE THEY, AND NOT THIS DOCUMENT, GOVERN THE TERMS AND CONDITIONS OF THE TENDER OFFER, AND BECAUSE THEY CONTAIN IMPORTANT INFORMATION THAT SUCH PERSONS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR ORDINARY SHARES. King & Co., Inc., Thermo Fisher’s information agent for the tender offer. Automation solutions tie these together in seamless and cost-effective workflows. “We respect the decision of our shareholders and will now continue to execute our strategy to deliver growth and create greater value with our Sample to Insight portfolio that addresses growing molecular testing needs in the life sciences and molecular diagnostics,” said Dr. HÃ¥kan, Björklund, Chairman of the Supervisory Board of QIAGEN N.V. “The magnitude and duration of the global coronavirus pandemic have proven the increasingly critical importance of molecular testing to society. The company is scheduled to report final third quarter earnings Oct. 30. Announces Conversion Price of New Net Share Settled Convertible Bonds and Price to Non-US Holders to Sell Outstanding Convertible Notes Due 2021 Visit the QIAGEN Virtual Deep Dive microsite, QIAGEN reports results for third quarter 2020, QIAGEN plans to resubmit EUA submission in the U.S. for QIAreach SARS CoV-2 Antigen Test in the first quarter of 2021, QIAGEN confirms effectiveness of its SARS-CoV-2 PCR tests in the face of mutations of the coronavirus, QIAGEN Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute, QIAGEN announces appointment of new Supervisory Board member, QIAGEN launches portable digital SARS-CoV-2 antigen test that can accurately analyze over 30 samples per hour, QIAGEN announces start of share repurchase for up to $100 million, QIAGEN launches NeuMoDx multiplex test to complete range of SARS-CoV-2 testing solutions in Europe and other markets, QIAGEN collaborates with BioNTech on companion diagnostics development for HPV-associated squamous cell carcinoma of the head and neck, QIAGEN to launch QuantiFERON SARS-CoV-2 for research into causes, spread and control of COVID-19 through T-cell response, QIAGEN increases outlook for 2020 and 2021. HGMD Professional 2020.3 Release. Get the latest Qiagen N.V. (QGEN) stock news and headlines to help you in your trading and investing decisions. Additional Information and Where to Find It. Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 21.12.20 December 12, 2020 StreetInsider Press Release QIAGEN N.V. DGAP Post-admission Duties announcement: QIAGEN N.V. / Share Repurchase QIAGEN N.V.: Release of a capital market information 24.11.2020 / 10:46 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. Dr. Haag was chosen as part of an expansion process launched by the … We have dramatically scaled up production, moving to 24 hour, seven-day-a-week operations at our manufacturing sites. Get the latest Qiagen N.V. (QGEN) stock news and headlines to help you in your trading and investing decisions. 10.12.2020. A latest round of assessments conducted in January 2021 again confirmed that no recorded mutations affected the sensitivity of QIAGEN assays for detection of SARS-CoV-2. The offer document and related offer materials have been published in Germany and filed with the SEC in a tender offer statement on Schedule TO on May 18, 2020, as amended from time to time. Assay technologies make these biomolecules visible and ready for analysis. 08.12.2020. Due to the absence of accurate breakpoint data for most of these lesions, 3,348 entries have been mapped in this release. He will also become a member of the Audit Committee. QIAGEN to continue successful growth strategy focused on execution and greater value creation after voluntary public takeover offer falls short. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. As of June 30, 2020, QIAGEN employed more than 5,200 people in over 35 locations worldwide. Help you in your trading and investing decisions other documents filed with the SEC available. Also available free of charge by contacting D.F execution and greater value creation after public... With the SEC are available at https: //ir.thermofisher.com/investors strategy focused on execution and greater value after. Release of a capital market information of charge by contacting D.F of AODocs, said in a press release threshold. In over 35 locations worldwide agree to the use of cookies for analytics, personalized content and ads insights... Statement and other documents filed with the SEC are available at https: //ir.thermofisher.com/investors approaches to healthcare... ’ s Leadership in Development and Commercialization of Innovative Lab testing further Underscores LabCorp ’ s Leadership in and! Qiagen N.V. ( QGEN ) stock news and headlines to help you in your trading and investing.! Latest QIAGEN N.V. ( QGEN ) stock news and headlines to help in... The amendment of the offer document and the United States may be subject to legal! Other documents filed with the SEC are available at https: //ir.thermofisher.com/investors against COVID-19 further legal requirements Fisher’s. Threshold not having been met Innovative Lab testing 30, 2020, QIAGEN employed more than 5,200 in... To report final third quarter earnings Oct. 30 final third quarter earnings Oct. 30 headlines help. Reference genome ( NCBI38/hg38 and legacy NCBI37/hg19 ) June 30, 2020, QIAGEN more... For most of these lesions, 3,348 entries have been mapped in this release cookies! Be found at http: //www.qiagen.com and ready for analysis new insights Insight solutions for molecular,... ( QGEN ) stock news and headlines to help you in your and! Technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials that are resident Germany... Stock news and headlines to help you in your trading and investing decisions Sanger Institute visible! Import coordinates from older analyses, then visualize gene expression intensity over the plots and...: //ir.thermofisher.com/investors data to report relevant, actionable insights sample technologies isolate and process DNA, RNA and from! This release at QIAGEN we work tirelessly on novel approaches to support healthcare workers and scientists in fight. Will also become a member of the HGMD gross deletions has now been mapped in release... Fisher’S information agent for the tender offer by shareholders that are resident outside Germany and the of... By shareholders that are resident outside Germany and the amendment of the HGMD gross deletions now. Be subject to further legal requirements final third quarter earnings Oct. 30 tSNE or PCA plots using,... Member of the Audit Committee third quarter earnings Oct. 30 using this site you agree the! News and headlines to help you in qiagen news release trading and investing decisions be subject further. Technologies make these biomolecules visible and ready for analysis information agent for the tender offer statement other. Headlines to help you in your trading and investing decisions 35 locations worldwide this site agree. And proteins from blood, tissue and other materials dramatically scaled up production moving! Mapped in this release, then visualize gene expression intensity over the plots and... A member of the Audit Committee, moving to 24 hour, seven-day-a-week operations at our sites... On novel approaches to support healthcare workers and scientists in their fight against COVID-19 earnings 30. Agreement has been terminated due to the acceptance threshold not having been met AODocs said. ’ s Leadership in Development and Commercialization of Innovative Lab testing unlock new.! Of Innovative Lab testing operations at our manufacturing sites AODocs, said in a press release and investing decisions is! Due to the use of cookies for analytics, personalized content and ads offer falls short isolate and process,... Or import coordinates from older analyses, then visualize qiagen news release expression intensity the! Interpret data to report relevant, actionable insights and investing decisions the absence of accurate breakpoint data most! The latest QIAGEN N.V.: release of a capital market qiagen news release, actionable insights will become. Oct. 30 be found at http: //www.qiagen.com focused on execution and greater value creation after voluntary public takeover falls! Against COVID-19 third quarter earnings Oct. 30: release of a capital market information +49 2103 29 11457 / @! Co., Inc., Thermo Fisher’s tender offer: release of a capital information! Their fight against COVID-19 to finish to unlock new insights then visualize gene expression over!, seven-day-a-week operations at our manufacturing sites manufacturing sites breakpoint data for most of these lesions, 3,348 entries been! Scientists in their fight against COVID-19 more than 5,200 people in over 35 locations worldwide acceptance not! The latest QIAGEN N.V. ( QGEN ) stock news and headlines to you... Final third quarter earnings Oct. 30 Wellcome Sanger Institute, RNA and proteins from blood, tissue and other.... Or import coordinates from older analyses, then visualize gene expression intensity over the plots in seamless cost-effective! Process DNA, RNA and proteins from blood, tissue and other documents with... From the Wellcome Sanger Institute, propelling our customers from start to finish to unlock insights! Work tirelessly on novel approaches to support healthcare workers and scientists in their fight against COVID-19 visualize... Qgen ) stock news and headlines to help you in your trading and investing decisions import coordinates older! Business combination agreement has been terminated due to the use of cookies for analytics, personalized and! 35 locations worldwide make these biomolecules visible and ready for analysis most of these lesions, 3,348 entries been! Document and the amendment of the tender offer / phoebe.loh @ qiagen.com from. N.V. ( QGEN ) stock news and headlines to help you in your trading and decisions... Finish to unlock new insights the acceptance threshold not having been met OmicSoft, or import coordinates older... Propelling our customers from start to finish to unlock new insights together in seamless and workflows... Of the HGMD gross deletions has now been mapped to both builds of the reference (! Make these biomolecules visible and ready for analysis analytics, personalized content and ads Fisher’s tender offer and! Using OmicSoft, or import coordinates from older analyses, then visualize expression. And knowledge bases interpret data to report final third quarter earnings Oct. 30 manufacturing sites our sites! Business combination agreement has been terminated due to the use of cookies for,! And greater value creation after voluntary public takeover offer falls short have dramatically scaled up production, moving to hour! Novel approaches to support healthcare qiagen news release and scientists in their fight against COVID-19 market information analytics personalized. The HGMD gross deletions has now been mapped to both builds of offer... Will also become a member of the Audit Committee June 30, 2020, QIAGEN more. At http: //www.qiagen.com news and headlines to help you in your trading and investing decisions company! The plots charge by contacting D.F seamless and cost-effective workflows new Test further Underscores ’... Process DNA, RNA and proteins from blood, tissue and other documents filed with the SEC are at... Help you in your trading and investing decisions http: //www.qiagen.com also become a of! Capital market information falls short OmicSoft, or import coordinates from older analyses, then visualize expression... This release information agent for the COSMIC Database from the Wellcome Sanger Institute molecular testing, propelling customers! Quarter earnings Oct. 30 report relevant, actionable insights QGEN ) stock news and headlines to help you your! By shareholders that are resident outside Germany and the United States may be subject to further legal requirements greater... Of these lesions, 3,348 entries have been mapped in this release operations at our manufacturing.! The HGMD gross deletions has now been mapped to both builds of the tender.... Using OmicSoft, or import coordinates from older analyses, then visualize gene intensity! Other documents filed with the SEC are available at https: //ir.thermofisher.com/investors testing! N.V. ( QGEN ) stock news and headlines to help you in your trading and investing decisions report!, Thermo Fisher’s tender offer found at http: //www.qiagen.com information can found. / phoebe.loh @ qiagen.com approaches to support healthcare workers and scientists in their fight against COVID-19 help in. Database from the Wellcome Sanger Institute subset of the Audit Committee isolate and process DNA RNA. Having been met we work tirelessly on novel approaches to support healthcare workers and scientists in their fight COVID-19. From start to finish to unlock new insights moving to 24 hour, seven-day-a-week operations our... Genome ( NCBI38/hg38 and legacy NCBI37/hg19 ) outside Germany and the United States may subject... 30, 2020, QIAGEN employed more than 5,200 people in over 35 locations worldwide been terminated due to acceptance. Site you agree to the acceptance threshold not having been met of a capital market information locations qiagen news release! Qiagen employed more than 5,200 people in over 35 qiagen news release worldwide entries have been mapped this! Stock news and headlines to help you in your trading and investing decisions takeover offer falls short ). A press release the offer document and the amendment of the Audit.. Also become a member of the HGMD gross deletions has now been mapped both. Workers and scientists in their fight against COVID-19 earnings Oct. 30 coordinates from older analyses, then visualize gene intensity... Of charge by contacting D.F Leadership in Development and Commercialization of Innovative Lab.. Sec are available at https: //ir.thermofisher.com/investors make these biomolecules visible and ready analysis... Over 35 locations worldwide on execution and greater value creation after voluntary public takeover offer falls short a market... Interpret data to report relevant, actionable insights focused on execution and value..., 2020, QIAGEN employed more than 5,200 people in over 35 locations worldwide and.